April 4, 2014

Mr. Ernie Hardeman: Mr. Speaker, I beg leave to present a report on diluted chemotherapy drugs from the Standing Committee on Social Policy and move the adoption of its recommendations.

The Speaker (Hon. Dave Levac): Mr. Hardeman presents the committee’s report and moves the adoption of the recommendations.

Does the member wish to make a brief statement?

Mr. Ernie Hardeman: Mr. Speaker, this report is the culmination of weeks of hearings and deliberations beginning in April of 2013, after the discovery that 1,212 patients in Ontario and New Brunswick had received diluted doses of two chemotherapy drugs. Key participants in the discovery and subsequent response appeared before the committees in April, May, June, September and October of 2013. The report contains the committee’s finding and makes recommendations to help ensure that this does not happen again.

I want to thank everyone who appeared before the committee for their contributions and commend the members of the committee for their diligence. I ask the assembly to give it full consideration.

With that, I move adjournment of the debate.
The Speaker (Hon. Dave Levac): Mr. Hardeman moves the adjournment of debate. Is it the pleasure of the House that the motion carry? Carried.
Debate adjourned.